Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Re: Radiology-led lung escalation pathway: a streamlined innovative service expediting the diagnosis of lung cancer.

Nanapragasam A, Ledson M, Walshaw M.

Clin Radiol. 2018 Jul;73(7):673. doi: 10.1016/j.crad.2018.02.020. Epub 2018 Apr 5. No abstract available.

PMID:
29628117
2.

Evaluating the effects of herbicide drift on nontarget terrestrial plants: A case study with mesotrione.

Brain RA, Perine J, Cooke C, Ellis CB, Harrington P, Lane A, O'Sullivan C, Ledson M.

Environ Toxicol Chem. 2017 Sep;36(9):2465-2475. doi: 10.1002/etc.3786. Epub 2017 Apr 4.

PMID:
28262983
3.

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM.

Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.

4.

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rassl DM, Rintoul RC, Screaton NJ, Wald NJ, Weller D, Williamson PR, Yadegarfar G, Hansell DM.

Thorax. 2016 Feb;71(2):161-70. doi: 10.1136/thoraxjnl-2015-207140. Epub 2015 Dec 8.

5.

The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.

McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M, Screaton N, Rintoul RC, Hands CJ, Lifford K, Whynes D, Kerr KM, Page R, Parmar M, Wald N, Weller D, Williamson PR, Myles J, Hansell DM, Duffy SW, Field JK.

Cancer Prev Res (Phila). 2014 Mar;7(3):362-71. doi: 10.1158/1940-6207.CAPR-13-0206. Epub 2014 Jan 17.

6.

Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients.

Fothergill JL, Ledson MJ, Walshaw MJ, McNamara PS, Southern KW, Winstanley C.

J Cyst Fibros. 2013 Dec;12(6):675-81. doi: 10.1016/j.jcf.2013.04.007. Epub 2013 May 29.

7.

Abdominal trauma and lung nodules.

Nazareth D, Seshadri N, Binukrishnan S, Ledson M, Walshaw M, Mohan K.

Postgrad Med J. 2013 Jun;89(1052):366. doi: 10.1136/postgradmedj-2012-131359. Epub 2013 Jan 15. No abstract available.

PMID:
23322745
8.

Fracture and intra-cardiac embolisation of a totally implantable vascular access device.

Nazareth D, Stables R, Ledson M, Walshaw M, Greenwood J.

Respiration. 2012;83(6):553. doi: 10.1159/000337255. Epub 2012 Apr 20. No abstract available.

9.

Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.

Ashish A, Shaw M, McShane J, Ledson MJ, Walshaw MJ.

JRSM Short Rep. 2012 Feb;3(2):12. doi: 10.1258/shorts.2011.011119. Epub 2012 Feb 27.

10.

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern?

Ashish A, Shaw M, Winstanley C, Ledson MJ, Walshaw MJ.

J Cyst Fibros. 2012 May;11(3):173-9. doi: 10.1016/j.jcf.2011.11.004. Epub 2011 Dec 5.

11.

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1674-9. doi: 10.1164/rccm.201009-1430OC. Epub 2011 Feb 4.

PMID:
21297072
12.

Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.

Fothergill JL, Mowat E, Walshaw MJ, Ledson MJ, James CE, Winstanley C.

Antimicrob Agents Chemother. 2011 Jan;55(1):426-8. doi: 10.1128/AAC.01257-10. Epub 2010 Oct 25.

13.

Self-care and cystic fibrosis: a review of research with adults.

Greenop D, Glenn S, Ledson M, Walshaw M.

Health Soc Care Community. 2010 Nov;18(6):653-61. doi: 10.1111/j.1365-2524.2010.00939.x. Review.

PMID:
20584088
14.

Haemoptysis, weight loss, and pulmonary shadowing in a smoker.

Jordan T, Ledson MJ, Mohan K.

BMJ. 2010 Apr 28;340:c1655. doi: 10.1136/bmj.c1655. No abstract available.

PMID:
20427454
15.

Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections.

Fothergill JL, White J, Foweraker JE, Walshaw MJ, Ledson MJ, Mahenthiralingam E, Winstanley C.

J Clin Microbiol. 2010 Jun;48(6):2053-9. doi: 10.1128/JCM.00019-10. Epub 2010 Apr 21.

16.

Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patient.

Mohan K, Lakshman V, Fothergill JL, Ledson MJ, Winstanley C, Walshaw MJ.

J Med Microbiol. 2010 May;59(Pt 5):614-6. doi: 10.1099/jmm.0.014696-0. Epub 2010 Feb 4.

PMID:
20133415
17.

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.

Fothergill JL, Mowat E, Ledson MJ, Walshaw MJ, Winstanley C.

J Med Microbiol. 2010 Apr;59(Pt 4):472-81. doi: 10.1099/jmm.0.015875-0. Epub 2009 Dec 17.

PMID:
20019149
18.

Mechanisms of glucose intolerance in cystic fibrosis.

Mohan K, Miller H, Dyce P, Grainger R, Hughes R, Vora J, Ledson M, Walshaw M.

Diabet Med. 2009 Jun;26(6):582-8. doi: 10.1111/j.1464-5491.2009.02738.x.

PMID:
19538232
19.

Simultaneous bilateral spontaneous pneumothorax in an adult patient with cystic fibrosis.

Mohan K, Ledson MJ, Walshaw MJ, Marchiori E.

J Bras Pneumol. 2009 Feb;35(2):194-6.

20.

Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat.

Mohan K, Fothergill JL, Storrar J, Ledson MJ, Winstanley C, Walshaw MJ.

Thorax. 2008 Sep;63(9):839-40. doi: 10.1136/thx.2007.092486.

PMID:
18728207
21.

Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.

Mohan K, Miller H, Burhan H, Ledson MJ, Walshaw MJ.

Pediatr Pulmonol. 2008 Jul;43(7):642-7. doi: 10.1002/ppul.20831.

PMID:
18500737
22.

Long-term effect of insulin treatment in cystic fibrosis-related diabetes.

Mohan K, Israel KL, Miller H, Grainger R, Ledson MJ, Walshaw MJ.

Respiration. 2008;76(2):181-6. Epub 2007 Oct 25.

PMID:
17960051
23.

Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients.

Al-Aloul M, Jackson M, Bell G, Ledson M, Walshaw M.

J Cyst Fibros. 2007 Jan;6(1):41-7. Epub 2006 Jun 27.

24.

Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES).

Al-Aloul M, Miller H, Stockton P, Ledson MJ, Walshaw MJ.

J Cyst Fibros. 2005 Sep;4(3):197-201.

25.

Burkholderia infection and survival in CF.

Ledson MJ, Walshaw MJ.

Thorax. 2005 May;60(5):439. No abstract available.

26.
27.

Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ.

Pediatr Pulmonol. 2005 Jan;39(1):15-20.

PMID:
15521084
28.

Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.

Mirakhur A, Gallagher MJ, Ledson MJ, Hart CA, Walshaw MJ.

J Cyst Fibros. 2003 Mar;2(1):19-24.

29.

PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.

Panagea S, Winstanley C, Parsons YN, Walshaw MJ, Ledson MJ, Hart CA.

Mol Diagn. 2003;7(3-4):195-200.

PMID:
15068391
30.

Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.

Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ.

Thorax. 2004 Apr;59(4):334-6.

31.

Bronchoscopic insertion of Gianturco stents for the palliation of malignant lung disease: 10 year experience.

Stockton PA, Ledson MJ, Hind CR, Walshaw MJ.

Lung Cancer. 2003 Oct;42(1):113-7.

PMID:
14512195
32.

Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.

McCallum SJ, Gallagher MJ, Corkill JE, Hart CA, Ledson MJ, Walshaw MJ.

Thorax. 2002 Jun;57(6):559-60.

33.

A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.

Ledson MJ, Gallagher MJ, Robinson M, Cowperthwaite C, Williets T, Hart CA, Walshaw MJ.

J Aerosol Med. 2002 Spring;15(1):51-7.

PMID:
12006145
34.

Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ.

Thorax. 2002 Feb;57(2):142-5.

35.

Persistent superior vena caval syndrome due to totally implantable venous access systems.

Stockton PA, Ledson MJ, Walshaw MJ.

J R Soc Med. 2001 Nov;94(11):584-5. Review. No abstract available.

36.

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ.

Lancet. 2001 Aug 18;358(9281):558-60.

PMID:
11520530
37.

Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients.

Ledson M, Gallagher M, Hart CA, Walshaw M.

Eur Respir J. 2001 Jan;17(1):36-8.

38.

Nebulised taurolidine and B cepacia bronchiectasis.

Ledson MJ, Cowperthwaite C, Walshaw MJ, Gallagher MJ, Williets T, Hart CA.

Thorax. 2000 Jan;55(1):91-2. No abstract available.

39.

A large pelvic arteriovenous malformation in an adult patient with cystic fibrosis.

Ledson MJ, Wahbi Z, Harris P, Walshaw MJ.

Postgrad Med J. 1999 Jun;75(884):353-4.

40.

Targeting DNase in cystic fibrosis.

Ledson Mj, Walshaw MJ.

Thorax. 1999 May;54(5):470. No abstract available.

41.

Epithelioid haemangioendothelioma.

Ledson MJ, Convery R, Carty A, Evans CC.

Thorax. 1999 Jun;54(6):560-1.

42.

Targeting of dornase alpha therapy in adult cystic fibrosis.

Ledson MJ, Wahbi Z, Convery RP, Cowperthwaite C, Heaf DP, Walshaw MJ.

J R Soc Med. 1998 Jul;91(7):360-4.

43.

Four years' experience of intravenous colomycin in an adult cystic fibrosis unit.

Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ.

Eur Respir J. 1998 Sep;12(3):592-4.

44.

Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual.

Ledson MJ, Gallagher MJ, Walshaw MJ.

Thorax. 1998 May;53(5):430-2.

45.

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.

Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ.

Thorax. 1998 May;53(5):432-6.

46.

Tracheal microaspiration in adult cystic fibrosis.

Ledson MJ, Wilson GE, Tran J, Walshaw MJ.

J R Soc Med. 1998 Jan;91(1):10-2.

47.
48.

Facial swelling in a patient with sarcoidosis.

Ledson MJ, Walton MC, Hind CR.

Postgrad Med J. 1997 Mar;73(857):181-2. No abstract available.

49.

An audit of lipid screening and management in patients undergoing diagnostic cardiac catheterization. Brompton House Officer Audit Group.

Stables RH, Choudhury RP, Davies WG, Denton MD, Ledson M, Rakhit RD, Varma C.

Eur Heart J. 1996 Nov;17(11):1657-62.

PMID:
8922913
50.

Re: Endocarditis in chronic liver disease.

Beales IL, Ledson M.

Am J Gastroenterol. 1994 Dec;89(12):2279. No abstract available.

PMID:
7977267

Supplemental Content

Loading ...
Support Center